Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide- stimulated rat primary astrocytes

Neurochemical Research

Volumn 33, Issue 11, 2008, Pages 2324-2334

  Lee, Soon Young ^a   Kim, Hee Jin ^b   Lee, Woo Jong ^c   Joo, So Hyun ^a   Jeon, Se Jin ^c   Kim, Ji Woon ^a   Kim, Hee Sun ^a   Han, Seol Heui ^a   Lee, Jongmin ^a   Park, Seung Hwa ^a   Cheong, Jae Hoon ^b   Kim, Won Ki ^d   Ko, Kwang Ho ^c   Shin, Chan Young ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Sahmyook University   (South Korea)

^c Seoul National University   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Isoproterenol; PAI 1; Post transcriptional control; Promoter activity; RT PCR; Zymography

Indexed keywords

BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GELATINASE B; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; ROLIPRAM; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; DNA PRIMERS; ENZYME ACTIVATION; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; TISSUE PLASMINOGEN ACTIVATOR;

RATTUS;

EID: 52549111578     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9737-2     Document Type: Article

References (62)

1. JC Adair J Charlie JE Dencoff JA Kaye JF Quinn RM Camicioli WG Stetler-Stevenson GA Rosenberg 2004 Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease Stroke 35 e159 e162
2. D Anthony K Miller S Fearn M Townsend G Opdenakker G Wells J Clements S Chandler A Gearing V Perry 1998 Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS J Neuroimmunol 87 62 72
3. K Arai SR Lee EH Lo 2003 Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes Glia 43 254 264
4. M Asahi X Wang T Mori T Sumii J Jung M Moskowitz M Fini E Lo 2001 Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia J Neurosci 21 7724 7732
5. M Asahina Y Yoshiyama T Hattori 2001 Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain Clin Neuropathol 20 60 63
6. JR Backstrom GP Lim MJ Cullen ZA Tokes 1996 Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40) J Neurosci 16 7910 7919
7. CR Balistreri G Candore F Listì T Fazio S Gangi E Incalcaterra M Caruso ML Vecchi D Lio C Caruso 2007 Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging Ann NY Acad Sci 1119 203 207
8. JM Bator RL Cohen DA Chambers 1998 Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes Exp Cell Res 242 110 119
9. M Cacquevel S Launay H Castel K Benchenane S Chéenne L Buée L Moons A Delacourte P Carmeliet D Vivien 2007 Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms Neurobiol Dis 27 164 173
10. P Carmeliet L Moons R Lijnen M Baes V Lemaitre P Tipping A Drew Y Eeckhout S Shapiro F Lupu D Collen 1997 Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat Genet 17 439 444
11. N Chauvet K Palin D Verrier S Poole R Dantzer J Lestage 2001 Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide Eur J NeuroSci 14 609 617
12. PB Daniel W Lux AL Samson WD Schleuning B Niego TW Weiss A Tjärnlund-Wolf RL Medcalf 2007 Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor FEBS J 274 2411 2423
13. M Del Bigio J Tchelingerian C Jacque 1999 Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells Neuropathol Appl Neurobiol 25 54 62
14. W Eberhardt C Engels R Müller J Pfeilschifter 2002 Mechanisms of dexamethasone-mediated inhibition of cAMP-induced tPA expression in rat mesangial cells Kidney Int 62 809 821
15. M Fernandez-Monreal JP Lopez-Atalaya K Benchenane F Leveille M Cacquevel L Plawinski ET MacKenzie G Bu A Buisson D Vivien 2004 Is tissue-type plasminogen activator a neuromodulator? Mol Cell Neurosci 25 594 601
16. A Flex E Gaetani AS Proia G Pecorini G Straface F Biscetti G Fioroni A Sabusco R Flore P Tondi P Pola R Pola 2006 Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease J Gerontol A Biol Sci Med Sci 61 1065 1069
17. C Gabriel C Ali S Lesné M Fernández-Monreal F Docagne L Plawinski ET MacKenzie A Buisson D Vivien 2003 Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity FASEB J 17 277 279
18. E Galea DL Feinstein DJ Reis 1992 Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures Proc Natl Acad Sci USA 89 10945 10949
19. E Ganea M Trifan AC Laslo G Putina C Cristescu 2007 Matrix metalloproteinases: useful and deleterious Biochem Soc Trans 35 689 691
20. G Giannelli J Falk-Marzillier O Schiraldi WG Stetler-Stevenson V Quaranta 1997 Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 Science 277 225 228
21. K Gijbels P Proost S Masure H Carton A Billiau G Opdenakker 1993 Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein J Neurosci Res 36 432 440
22. LE Goldfinger MS Stack JC Jones 1998 Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator J Cell Biol 141 255 265
23. PE Gottschall X Yu 1995 Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes J Neurochem 64 1513 1520
24. A Gualandris TE Jones S Strickland SE Tsirka 1996 Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator J Neurosci 16 2220 2225
25. V Junker A Becker R Hühne M Zembatov A Ravati C Culmsee J Krieglstein 2002 Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection Eur J Pharmacol 446 25 36
26. SD Kim SI Yang HC Kim CY Shin KH Ko 2007 Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte Brain Res 1186 12 20
27. Kingston IB, Castro MJ, Anderson S (1995) In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat Med 1:138-142
28. M Kitazawa S Oddo TR Yamasaki KN Green FM LaFerla 2005 Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J Neurosci 25 8843 8853
29. Kranenburg O, Bouma B, Gent YY, Aarsman CJ, Kayed R, Posthuma G, Schiks B, Voest EE, Gebbink MF (2005) Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation. Mol Cell Neurosci 28:496-508
30. WJ Lee CY Shin BK Yoo JR Ryu EY Choi JH Cheong JH Ryu KH Ko 2003 Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2) Glia 41 15 24
31. SR Lee SZ Guo RH Scannevin BC Magliaro KJ Rhodes X Wang EH Lo 2007 Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators Neurosci Lett 417 1 5
32. JE Lochner LS Honigman WF Grant SK Gessford AB Hansen MA Silverman BA Scalettar 2006 Activity-dependent release of tissue plasminogen activator from the dendritic spines of hippocampal neurons revealed by live-cell imaging J Neurobiol 66 564 577
33. S Lorenzl DS Albers N Relkin T Ngyuen SL Hilgenberg J Chirichigno ME Cudkowicz MF Beal 2003 Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease Neurochem Int 43 191 196
34. Masos T, Miskin R (1997) mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Brain Res Mol Brain Res 47:157-169
35. LJ McCawley S Li M Benavidez J Halbleib EV Wattenberg LG Hudson 2000 Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration Mol Pharmacol 58 145 151
36. Medina MG, Ledesma MD, Domínguez JE, Medina M, Zafra D, Alameda F, Dotti CG, Navarro P (2005) Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 24:1706-1716
37. Melchor JP, Pawlak R, Strickland S (2003) The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 23:8867-8871
38. JP Melchor S Strickland 2005 Tissue plasminogen activator in central nervous system physiology and pathology Thromb Haemost 93 655 660
39. L Oh P Larsen C Krekoski D Edwards F Donovan Z Werb V Yong 1999 Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes J Neurosci 19 8464 8475
40. K Pahan FG Sheikh M Khan AM Namboodiri I Singh 1998 Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes J Biol Chem 273 2591 2600
41. A Probst H Lill K Strein 1988 Beta-adrenergic receptor mediated release of tissue plasminogen activator in anaesthetized dogs Thromb Res 50 9 17
42. G Rosenberg M Kornfeld E Estrada R Kelley L Liotta W Stetler-Stevenson 1992 TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase Brain Res 576 203 207
43. CY Shin JW Choi JR Ryu JH Ryu W Kim H Kim KH Ko 2001 Immunostimulation of rat primary astrocytes decreases intracellular ATP level Brain Res 902 198 204
44. CY Shin M Kundel DG Wells 2004 Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation J Neurosci 24 9425 9433
45. Shin CY, Lee WJ, Choi JW, Choi MS, Ryu JR, Oh SJ, Cheong JH, Choi EY, Ko KH (2007) Down-regulation of matrix metalloproteinase-9 expression by nitric oxide in lipopolysaccharide-stimulated rat primary astrocytes. Nitric Oxide 16:425-432
46. Siao CJ, Fernandez SR, Tsirka SE (2003) Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 23:3234-3242
47. CJ Siao SE Tsirka 2002 Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II J Neurosci 22 3352 3358
48. LM Sly RF Krzesicki JR Brashler AE Buhl DD McKinley DB Carter JE Chin 2001 Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease Brain Res Bull 56 581 588
49. S Takahashi A Ito M Nagino Y Mori B Xie H Nagase 1991 Cyclic adenosine 3′, 5′-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts J Biol Chem 266 19894 19899
50. Tong H, Bernstein D, Murphy E, Steenbergen C (2005) The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 19:983-985
51. P Tranque R Robbins F Naftolin P Andrade-Gordon 1992 Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes Glia 6 163 171
52. K Tsuji T Aoki E Tejima K Arai SR Lee DN Atochin PL Huang X Wang J Montaner EH Lo 2005 Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia Stroke 36 1954 1959
53. J Uhm N Dooley L Oh V Yong 1998 Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix Glia 22 53 63
54. VA Vincent CW Löwik JH Verheijen AC de Bart FJ Tilders AM Van Dam 1998 Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells Glia 22 130 137
55. X Wang SR Lee K Arai SR Lee K Tsuji GW Rebeck EH Lo 2003 Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator Nat Med 9 1313 1317
56. SA Willis PD Nisen 1996 Differential induction of the mitogen-activated protein kinase pathway by bacterial lipopolysaccharide in cultured monocytes and astrocytes Biochem J 313 519 524
57. MS Woo SH Jung JW Hyun HS Kim 2004 Differential regulation of inducible nitric oxide synthase and cytokine gene expression by forskolin and dibutyryl-cAMP in lipopolysaccharide-stimulated murine BV2 microglial cells Neurosci Lett 356 187 190
58. MS Woo SH Jung SY Kim JW Hyun KH Ko WK Kim HS Kim 2005 Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells Biochem Biophys Res Commun 335 1017 1025
59. P Yan X Hu H Song K Yin RJ Bateman JR Cirrito Q Xiao FF Hsu JW Turk J Xu CY Hsu DM Holtzman JM Lee 2006 Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ J Biol Chem 281 24566 24574
60. V Yong C Krekoski P Forsyth R Bell D Edwards 1998 Matrix metalloproteinases and diseases of the CNS Trends Neurosci 21 75 80
61. BQ Zhao E Tejima EH Lo 2007 Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke Stroke 38 2 Suppl 748 752
62. J Zuo T Ferguson Y Hernandez W Stetler-Stevenson D Muir 1998 Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan J Neurosci 18 5203 5211